Coronavirus Q&A: Buchanan Ingersoll's FDA Chair
In an interview with Law360, the co-chair of the U.S. Food and Drug Administration practice at Buchanan Ingersoll & Rooney PC shared his advice for dealing with the agency during the...To view the full article, register now.
Already a subscriber? Click here to view full article